Patrick Hurban, Ph.D. | January 27, 2016

Genomics throughout the Drug Development Process by Patrick Hurban

The final entry of 3 video blog series by Patrice Hugo, Ph.D. Chief Scientific Officer
Genomic technologies can be applied in all phases of the drug development process. In the last of a three-part video series, Patrick Hurban, Ph.D., senior director and global head, Genomic Development/Esoteric Assays at Q2 Solutions, discusses the impact of genomic technologies from early research and development and discovery to clinical development.  In addition he explains why the adoption of genomic technologies is important throughout the project lifecycle.

Watch part three

Related Services: